genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
uniQure
GEN Edge
StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares
GEN Edge
StockWatch: As Illumina Expands in Multiomics, Analyst Sees Threat to 10x
Genome Editing
UniQure Says It Will Not Pursue EC Marketing Renewal for Glybera Gene Therapy
Industry News
uniQure Axing 50 to 60 Positions in Restructuring
Genome Editing
uniQure Expands Gene Therapy Stable with InoCard Acquisition
Drug Discovery
uniQure and Benitec Enter Cross-Licensing Agreement
Genome Editing
First Gene Therapy One Step Away from European Sanction
Genome Editing
uniQure, UCSF Partner on Parkinson Disease Gene Therapy Trial
Scroll Up
Scroll Up
